logo
logo
ITI Pharma and Healthcare Fund

ITI Pharma and Healthcare Fund

1–7 yearsInvestment Horizon

Performance and Risk Analysis

Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.

Risk Profile

Risk Profile

Standard Deviation19.3%
Sharpe Ratio0.53
Beta0.99

Strategy Details

A closer look at the investment thesis, portfolio construction, and current holdings.

Portfolio Holdings Overview

Portfolio Holdings Overview

SectoralAllocation
Capital Goods4.57%
Services95.43%

Geographic Allocation

Domestic100%
Top Stock Holdings

Top Stock Holdings

CompanySectorAllocation
Sun Pharmaceuticals Industries LtdServices15.18%
Divi's Laboratories LtdServices9.12%
Max Healthcare Institute Ltd Ordinary SharesServices5.42%
Lupin LtdServices5.40%
Apollo Hospitals Enterprise LtdServices5.19%
Cohance Lifesciences LtdServices4.84%
Aurobindo Pharma LtdServices3.93%
Torrent Pharmaceuticals LtdServices3.91%
Aster DM Healthcare Ltd Ordinary SharesServices3.15%
Mankind Pharma LtdServices3.04%

Operational & Regulatory Details

What it costs to invest, transaction mechanics, and regulatory disclosures you should know.

iconCosts and Fees

Total Expense Ratio (TER)2.35%

iconRegulatory & Tax Information

INF00XX01BM3
verified
ISIN
DailyDealing Frequency
BSE Healthcare PRBenchmark

LTCG | >1Year 12.5%% on gain above 1.25 Lakh

STCG | <1Year 20%%

Tax Implications (India)
Let's Chat